TP53 and head and neck squamous cell carcinoma: Nevertheless, although p53 mutation occurs frequently in patients with SCCHN (Olivier et al, 2002), approximately half of these patients retain potentially functional wild-type p53 (in a recent systematic review, we identified a mutation frequency for SCCHN of 50.7% in the United Kingdom (Tandon et al, 2010)).